Transfection efficiency and cytotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells

Pharmaceutical Research

Volumn 21, Issue 6, 2004, Pages 1009-1017

  Kiefer, Karin ^a   Clement, Jule ^a   Garidel, Patrick ^b   Peschka Süss, Regine ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

cytotoxicity; human endothelial cells; nonviral gene transfer; smooth muscle cells; transfection efficiency

Indexed keywords

DAC 30; DC 30; DNA; EFFECTENE; LIPOFECTAMINE; LIPOFECTIN; LIPOSOME; PLASMID DNA; SUPERFECT; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DNA; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GERMANY; HUMANS; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; MUSCLE, SMOOTH, VASCULAR; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; QUALITY CONTROL; RATS; TRANSFECTION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 3042845524     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000029291.62615.ec     Document Type: Article

References (33)

1. R. Califf. Restenosis: The cost to society. Am. Heart J. 130:680-684 (1995).
2. W. McBride. Restenosis after successfull coronary angioplasty. Pathophysiology and prevention. N. Engl. J. Med. 318:1734-1737 (1988).
3. J. Dulak, A. Jozkowicz, I. Guevara, and A. Dembinska-Kiec. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase - implications for gene therapy in cardiovascular diseases. Pol. J. Pharmacol. 51:233-241 (1999).
4. K. Veit, J. P. Boissel, M. Buerke, T. Grosser, J. Meyer, and H. Darius. Highly efficient liposome-mediated gene transfer of inducible nitric oxide synthase in vivo and in vitro in vascular smooth muscle cells. Cardiovasc. Res. 43:808-822 (1999).
5. E. G. Nabel. Gene transfer into vascular cells. J. Am. Coll. Cardiol. 17:189B-194B (1991).
6. C. Bauters and J. M. Isner. The biology of restenosis. Prog. Cardiovasc. Dis. 40:107-116 (1997).
7. S. Armeanu, J. Pelisek, E. Krausz, A. Fuchs, D. Groth, R. Curth, O. Keil, J. Quilici, P. H. Rolland, R. Reszka, and S. Nikol. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol Ther 1:366-375 (2000).
8. S. G. Martin and J. C. Murray. Gene-transfer systems for human endothelial cells. stewart.martin@nottingham.ac.uk. Adv. Drug Deliv. Rev. 41:223-233 (2000).
9. E. Imai, Y. Akagi, and Y. Isaka. Towards gene therapy for renal diseases. Nephrologie 19:397-402 (1998).
10. Y. Yang, F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411 (1994).
11. P. L. Felgner, T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413-7417 (1987).
12. X. Gao and L. Huang. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:280-285 (1991).
13. S. U. Dani. The challenge of vector development in gene therapy. Braz. J. Med. Biol. Res. 32:133-145 (1999).
14. J. P. Schofield and C. T. Caskey. Non-viral approaches to gene therapy. Br. Med. Bull. 51:56-71 (1995).
15. R. Sipehia and G. Martucci. High-efficiency transformation of human endothelial cells by Apo E- mediated transfection with plasmid DNA. Biochem. Biophys. Res. Commun. 214:206-211 (1995).
16. M. Teifel, L. T. Heine, S. Milbredt, and P. Friedl. Optimization of transfection of human endothelial cells. Endothelium 5:21-35 (1997).
17. H. Faneca, S. Simoes, and M. C. de Lima. Evaluation of lipid-based reagents to mediate intracellular gene delivery. Biochim. Biophys. Acta 1567:23-33 (2002).
18. M. T. da Cruz, S. Simoes, P. P. Pires, S. Nir, and M. C. de Lima. Kinetic analysis of the initial steps involved in lipoplex - cell interactions: effect of various factors that influence transfection activity. Biochim. Biophys. Acta 1510:136-151 (2001).
19. K. K. Son, D. H. Patel, D. Tkach, and A. Park. Cationic liposome and plasmid DNA complexes formed in serum-free medium under optimum transfection condition are negatively charged. Biochim. Biophys. Acta 1466:11-15 (2000).
20. C. Kawaura, A. Noguchi, T. Furuno, and M. Nakanishi. Atomic force microscopy for studying gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. FEBS Lett. 421:69-72 (1998).
21. V. Escriou, M. Carriere, F. Bussone, P. Wils, and D. Scherman. Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer. J. Gene Med. 3:179-187 (2001).
22. S. Cornelis, M. Vandenbranden, J. M. Ruysschaert, and A. Elouahabi. Role of intracellular cationic liposome-DNA complex dissociation in transfection mediated by cationic lipids. DNA Cell Biol. 21:91-97 (2002).
23. D. I. Axel, I. Spyridopoulos, R. Riessen, H. Runge, R. Viebahn, and K. R. Karsch. Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptake. J Vasc Res 37: 221-34; discussion 303-4. (2000).
24. A. T. Young, J. R. Lakey, A. G. Murray, and R. B. Moore. Gene therapy: a lipofection approach for gene transfer into primary endothelial cells. Cell Transplant. 11:573-582 (2002).
25. S. Takeshita, D. Gal, G. Leclerc, J. G. Pickering, R. Riessen, L. Weir, and J. M. Isner. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J. Clin. Invest. 93:652-661 (1994).
26. J. H. Felgner, R. Kumar, C. N. Sridhar, C. J. Wheeler, Y. J. Tsai, R. Border, P. Ramsey, M. Martin, and P. L. Felgner. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269:2550-2561 (1994).
27. A. Abe, A. Miyanohara, and T. Friedmann. Polybrene increases the efficiency of gene transfer by lipofection. Gene Ther. 5:708-711 (1998).
28. B. Schwartz, M. A. Ivanov, B. Pitard, V. Escriou, R. Rangara, G. Byk, P. Wils, J. Crouzet, and D. Scherman. Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther. 6:282-292 (1999).
29. C. L. Gebhart and A. V. Kabanov. Evaluation of polyplexes as gene transfer agents. J. Control. Rel. 73:401-416 (2001).
30. E. Uchida, H. Mizuguchi, A. Ishii-Watabe, and T. Hayakawa. Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol. Pharm. Bull. 25:891-897 (2002).
31. M. C. Keogh, D. Chen, F. Lupu, N. Shaper, J. F. Schmitt, V. V. Kakkar, and N. R. Lemoine. High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid-DNA complex. Gene Ther. 4:162-171 (1997).
32. J. P. Yang and L. Huang. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 4:950-960 (1997).
33. E. Dodds, M. G. Dunckley, K. Naujoks, U. Michaelis, and G. Dickson. Lipofection of cultured mouse muscle cells: a direct comparison of Lipofectamine and DOSPER. Gene Ther. 5:542-551 (1998).